Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — 3rd Annual E&P Small Cap Healthcare Conference 2024
16 slides from Curvebeam Ai's conference presentation, Sep 26, 2024
Slide 1: ASX Announcement: Investor Presentation E&P Small Cap Healthcare Conference
ASX ANNOUNCEMENT ASX: CVB 26 September 2024 Investor Presentation E&P Small Cap Healthcare Conference CurveBeam AI Limited (ASX:CVB) (the Company) provides herewith a copy of a presentation being presented today by CEO Greg Brown at the E&P Small Cap Healthcare Conference. Release approved by the Bo
Slide 2: Investor Presentation, 3rd Annual E&P Small Cap Healthcare Conference
For personal use only INVESTOR PRESENTATION 3rd Annual E&P Small Cap Healthcare Conference Thursday 26 September 2024
Slide 3: Disclaimer
DISCLAIMER For personal use only Introduction Recipient agrees that if it proceeds further with its investigations, consideration or evaluation of investing in THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, CurveBeam it will not in any way rely upon this document
Slide 4: CurveBeam AI Highlights
DRAFT CURVEBEAM AI IS A MEDICAL DEVICE INVESTMENT COMPANY FOCUSED ON COMMERCIALISING WEIGHT BEARING CT SCANNERS & AI SAAS HIGHLIGHTS SOLUTIONS For personal use only • First to market, bilateral weight bearing CT scans First to market • Enhanced HiRiseTM CT provides in-office high-resolution 3D scans
Slide 5: Weight Bearing CT Overview
DRAFT W E I G H T B E A R I N G C T O V E RV I E W ü Quicker and easier to scan than traditional CT and MRI, ü Radiation dose lower than traditional CT – up to 66% less than For personal use only with faster image acquisition time traditional CT ü High resolution and 3D visualisation enables ü Small
Slide 6: CurveBeam AI CT Devices & AI Output
CURVEBEAM AI CT DEVICES & AI OUTPUT CurveBeam AI has a range of CT imaging devices with visualisation applications in orthopaedics and bone health For personal use only STRAXCORP – KEY POINTS ORTHOPAEDIC VISUALISATION & PLANNING BONE HEALTH CLINICAL AIDS What do we do? Addressing a major underserved
Slide 7: Strong Investment Proposition for Surgeons
STRONG INVESTMENT PROPOSITION FOR SURGEONS For personal use only Targeting existing reimbursement codes - creates an attractive financial model • The average Medicare reimbursement rate for scans of the lower extremity CPT code relevant to the HiRise™, pedCAT™ and LineUP™ was US$138.77 per scan in 2
Slide 8: Large Market Opportunity & Adoption by Leading Customers
LARGE MARKET OPPORTUNITY & ADOPTION BY LEADING CUSTOMERS For personal use only Potential US Addressable Market ~17,000+ potential Customers3 Examples installations (WBCT scanners only)1 (A$bn)2 • Mayo Clinics (all 3 major locations) Hospital Based • NYU Langone Health A$3.4bn • Medium to large hospi
Slide 9: Stryker Foot & Ankle Co-Marketing & Distribution US Partnership
STRYKER FOOT & ANKLE CO-MARKETING & DISTRIBUTION US PARTNERSHIP For personal use only US F&A division has access to 500 reps and 40 regional Sales Managers STRYKER CORPORATION (NYSE:SYK) BACKGROUND • May 2023, Stryker’s Foot & Ankle (F&A) division officially launched its HiRiseTM promotion, distribu
Slide 10: Stage 1 Second Fx Business Model: BMD and OssView Overview
S TA G E 1 – S E C O N D F X B U S I N E S S M O D E L An over 60 yr old fracture patient suspected of fragility fracture goes to FLS – non-osteoporosis – Impact or Frag BMD AND OSSVIEW OVERVIEW AWS AI SaaS solutions for CT scans – an automated BMD result for surgical planning For personal use only
Slide 11: Two Business Models
TWO BUSINESS MODELS Existing reimbursement codes/coverage targeted to drive both business models For personal use only 1. Present HiRise CT Business Model • Stryker sells HiRise for US$410,000 (circa A$630,000) Daily patient volume through a USA group surgeon office • CurveBeam AI transfers HiRise t
Slide 12: AI Modules Will Target Subscription Based SaaS
DRAFT A I M O D U L E S W I L L TA R G E T S U B S C R I P T I O N B A S E D S A A S For personal use only CubeVue AutoMetrics aims to reduce hours of surgeon time for pre-surgical planning to a scan available in 15 minutes APPLICATIONS THE PROBLEM THE SOLUTION • Suspected hip, knee and • Orthopaedi
Slide 13: Land & Expand Commercialisation Strategy
L A N D & E X PA N D C O M M E R C I A L I S AT I O N S T R AT E G Y Over 170 first & second-generation installations worldwide, CurveBeam AI is well placed to upgrade its global install base For personal use only NORTH AMERICA EUROPE • ~17,000+ potential installations Operations HQ (Penn.) 8 Distri
Slide 14: FY Quarterly Purchase Orders
F Y 2 4 Q U A R T E R LY P U R C H A S E O R D E R S CurveBeam AI’s LineUp and PedCat WBCT devices are no longer available - stock is now sold For personal use only Global WBCT purchase orders 10 7 6 4 4 3 3 3 3 3 0 0 FY24 Q 1 FY24 Q 2 FY24 Q 3 FY 24 Q4 Total orde rs HiRIse Lin eUp/PedCa t 13
Slide 15: Next Generation WBCT Platform: SkyRise
For personal use only Next Generation WBCT Platform: TM SKYRISE
Slide 16: Thank You
For personal use only THANK YOU
CurveBeam AI — 3rd Annual E&P Small Cap Healthcare Conference 2024 on 6ix